Form 4 for CRVO CervoMed Inc.
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-12 · accession 0001437749-25-034638 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-13 | 2025-11-12 | CRVO | ALAM JOHN J | CEO, Pres, Dir, 10% | P - Purchase | $7.35 | +5,553 | 1.47M | +0.4% | +$40.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-12 | P | A | 5,553 | $7.35 | 1,467,131 | D | — | — | (F1) Shares purchased in open-market transactions. (F2) Shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors. |